- Assistant Professor, CWRU School of Medicine
Robin Buerki, MD is a Neuro-oncologist at University Hospitals Cleveland Medical Center. Dr. Bueki clinically focuses on treating patients with primary central nervous system tumors and metastatic cancers to the brain and spinal cord, leptomeningeal metastases, and tumors associated with neurocutaneous syndromes, and the neurological complications of cancer and chemotherapy. He leads therapeutic clinical trials for tumor patients and works closely with Neurosurgery, Radiation oncology, and Neuropsychology colleagues.
Dr. Buerki has a particular interest in molecularly targeted therapies, radiation-related cognitive dysfunction in brain tumor patients, and secondary malignancies of childhood cancer survivors.
He is an active member of the Society of Neuro-Oncology, American Society of Clinical Oncology, and the Neuro-oncology section of the American Academy of Neurology.
Dr. Buerki and his wife Amy have an adorable daughter and have lived in Cleveland Heights since 2019.
- Brain Tumors
- Neurofibromatosis Type II
- Neurological Complications of Cancer
- Paraneoplastic Encephalitis
- Spinal Cord Tumors
- Neurology - American Board of Psychiatry and Neurology
Fellowship | Neuro-oncology
Neuro-oncology - University Of California San Francisco (2017 - 2019)
Residency | Neurology
Neurology - University Of Chicago Medical Center (2014 - 2017)
Internship | Internal Medicine
Internal Medicine - University Of Illinois At Chicago Medical Center (2013 - 2014)
Northwestern University Feinberg School Of Medicine (2013)
University Of Cambridge (2007)
Princeton University (2006)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Robin Buerki did not disclose any Outside Relationships with Industry.